Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Corradini

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Leukemia|March 10, 2001
High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicityC Tarella, F Zallio, D Caracciolo, et al.
Leukemia|July 19, 2014
The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphomaS Robinson, P Dreger, D Caballero, et al.
Leukemia|May 17, 2003
Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioningP Dreger, R Brand, J Hansz, et al.
British Journal of Haematology|December 24, 1997
Multiple myeloma: reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high-dose chemotherapy coursesP Omedè, C Tarella, A Palumbo, et al.
Experimental Hematology|February 13, 2001
A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patientsM Ladetto, S Sametti, J W Donovan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cellsP Corradini, C Voena, C Tarella, et al.
Leukemia|September 10, 2011
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effectA Dodero, F Spina, F Narni, et al.
Bone Marrow Transplantation|January 10, 2006
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancerM Bregni, K Fleischhauer, M Bernardi, et al.
Bone Marrow Transplantation|April 29, 2018
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamideA Mussetti, C De Philippis, C Carniti, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patientsT Guglielmelli, S Bringhen, S Rrodhe, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Leukemia|March 10, 2001
High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicityC Tarella, F Zallio, D Caracciolo, et al.
Leukemia|July 19, 2014
The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphomaS Robinson, P Dreger, D Caballero, et al.
Leukemia|May 17, 2003
Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioningP Dreger, R Brand, J Hansz, et al.
British Journal of Haematology|December 24, 1997
Multiple myeloma: reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high-dose chemotherapy coursesP Omedè, C Tarella, A Palumbo, et al.
Experimental Hematology|February 13, 2001
A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patientsM Ladetto, S Sametti, J W Donovan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cellsP Corradini, C Voena, C Tarella, et al.
Leukemia|September 10, 2011
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effectA Dodero, F Spina, F Narni, et al.
Bone Marrow Transplantation|January 10, 2006
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancerM Bregni, K Fleischhauer, M Bernardi, et al.
Bone Marrow Transplantation|April 29, 2018
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamideA Mussetti, C De Philippis, C Carniti, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patientsT Guglielmelli, S Bringhen, S Rrodhe, et al.
Pageof 12